Below is an alphabetical list of the 480 compounds in the BIOMOL
ICCB Known Bioactives collection (BIOMOL catalogue #2840). It includes
some information on the activity of each compound (note that these
descriptions
are incomplete here; for detailed information on individual compounds, please
see chembank), and ordering
information. The list also includes the concentration of compound
in the high concentration plate. The high concentration stocks
were diluted 4.56-fold in the Medium concentration plates. Thus,
a compound at 5 mg/ml in the high concentration plate will be at
~1.1 mg/ml in the medium concentration plate.
| COMPOUND NAME |
Action |
BIOMOL CAT # |
High Conc. in DMSO |
| (R)-METHANANDAMIDE |
Cannabinoid CB1 agonist |
FA021 |
1mM |
| 1,25-DIHYDROXYVITAMIN D3 |
|
DM200 |
1mM |
| 1,2-DIDECANOYL-GLYCEROL (10:0) |
|
DG100 |
1mM |
| 1,2-DIOCTANOYL-SN-GLYCEROL |
|
DG112 |
1mM |
| 1,2-DIOLEOYL-GLYCEROL (18:1) |
|
DG115 |
1mM |
| 10-hydroxycamptothecin |
topoisomerase 1 inhibitor |
GR-316 |
5mg/mL |
| 11,12-EPOXYEICOSATRIENOIC ACID |
|
EE11 |
0.1mM |
| 12(R)-HETE |
|
H112 |
0.1mM |
| 12(S)-HETE |
|
H012 |
0.1mM |
| 12(S)-HPETE |
|
HP012 |
0.1mM |
| 12-METHOXYDODECANOIC ACID |
|
G234 |
1mM |
| 13(S)-HODE |
|
HO013 |
0.1mM |
| 13(S)-HPODE |
|
HP013 |
0.1mM |
| 13,14-DIHYDRO-PGE1 |
|
PG048 |
1mM |
| 13-CIS RETINOIC ACID |
|
GR102 |
1mM |
| 13-KETOOCTADECADIENOIC ACID |
|
KO013 |
0.1mM |
| 14,15-EPOXYEICOSATRIENOIC ACID |
|
EE14 |
0.1mM |
| 1400W |
iNOS inhibitor |
CN-268 |
5mg/mL |
| 15(S)-HETE |
|
H015 |
0.1mM |
| 15(S)-HPETE |
|
HP015 |
0.1mM |
| 15d-Prostaglandin J2 |
|
PG050 |
1mM |
| 15-KETOEICOSATETRAENOIC ACID |
|
K-015 |
0.1mM |
| 16,16-DIMETHYL-PROSTAGLANDIN E2 |
|
PG-021 |
1mM |
| 17-Allylamino-geldanamycin |
HSP-90 inhibitor |
EI308 |
5mg/mL |
| 17-OCTADECYNOIC ACID |
|
EI-103 |
1mM |
| 17-PHENYL-TRINOR-PGE2 |
|
PG-042 |
1mM |
| 1-ACYL-PAF |
|
L-134 |
1mM |
| 1-HEXADECYL-2-ARACHIDONOYL-GLYCEROL |
|
DG-140 |
1mM |
| 1-HEXADECYL-2-METHYLGLYCERO-3 PC |
|
L-106 |
1mM |
| 1-HEXADECYL-2-O-ACETYL-GLYCEROL |
|
EI-150 |
1mM |
| 1-HEXADECYL-2-O-METHYL-GLYCEROL |
|
EI-149 |
1mM |
| 1-OCTADECYL-2-METHYLGLYCERO-3 PC |
|
L-108 |
1mM |
| 1-OLEOYL-2-ACETYL-GLYCEROL |
|
DG-125 |
1mM |
| 1-STEAROYL- 2-LINOLEOYL-GLYCEROL |
|
DG-135 |
1mM |
| 1-STEAROYL-2-ARACHIDONOYL-GLYCEROL |
|
DG-130 |
1mM |
| 2,5-ditertbutylhydroquinone |
ER Ca++ ATPase inhibitor |
CA-420 |
5mg/mL |
| 24(S)-hydroxycholesterol |
LXR agonist |
GR230 |
5mg/mL |
| 24,25-DIHYDROXYVITAMIN D3 |
|
DM300 |
1mM |
| 25-HYDROXYVITAMIN D3 |
|
DM100 |
1mM |
| 2-ARACHIDONOYLGLYCEROL |
Cannabinoid CB1 agonist |
FA028 |
1mM |
| 2-FLUOROPALMITIC ACID |
|
G231 |
1mM |
| 2-HYDROXYMYRISTIC ACID |
|
G230 |
1mM |
| 2-methoxyantimycin A3 |
Bcl-2/Bcl-XL ligand induces apoptosis |
CM-123 |
5mg/mL |
| 3,4-dichloroisocoumarin |
granzyme B inhibitor |
PI-110 |
5mg/mL |
| 4-AMINOPYRIDINE |
Potassium channels |
AC-119 |
5mg/mL |
| 4-HYDROXYPHENYLRETINAMIDE |
|
GR103 |
1mM |
| 4-OXATETRADECANOIC ACID |
|
G232 |
1mM |
| 5(S)-HETE |
|
H005 |
0.1mM |
| 5(S)-HPETE |
|
HP005 |
0.1mM |
| 5,6-EPOXYEICOSATRIENOIC ACID |
|
EE56 |
0.1mM |
| 5,8,11,14-EICOSATETRAYNOIC ACID |
|
ET004 |
1mM |
| 5,8,11-EICOSATRIYNOIC ACID |
|
ET003 |
1mM |
| 5-HYDROXYDECANOATE |
Potassium channels |
KC-141 |
5mg/mL |
| 5-iodotubercidin |
ERK-2 inhibitor |
EI-293 |
5mg/mL |
| 5-KETOEICOSATETRAENOIC ACID |
|
K005 |
0.1mM |
| 5'-N-Ethylcarboxamidoadenosine (NECA) |
adenosine receptor agonist |
AC601 |
5mg/mL |
| 6,7-ADTN HBr |
Dopamine agonist |
D-100 |
5mg/mL |
| 6-FORMYLINDOLO [3,2-B] CARBAZOLE |
AHR agonist |
GR206 |
1mM |
| 6-KETO-PROSTAGLANDIN F1a |
|
PG017 |
1mM |
| 7,7-DIMETHYLEICOSADIENOIC ACID |
PLA2 inhibitor |
EI-112 |
1mM |
| 8,9-EPOXYEICOSATRIENOIC ACID |
|
EE89 |
0.1mM |
| 8-EPI-PROSTAGLANDIN F2a |
|
PG049 |
1mM |
| 8-methoxymethyl-IBMX |
phosphodiesterase (PDE1) inhibitor |
PD-150 |
5mg/mL |
| 9(S)-HODE |
|
HO409 |
0.1mM |
| 9(S)-HPODE |
|
HP019 |
0.1mM |
| 9,10-OCTADECENOAMIDE |
|
FA025 |
1mM |
| 9a,11b-PROSTAGLANDIN F2 |
|
PG031 |
1mM |
| 9b,11a-PROSTAGLANDIN F2 |
|
PG030 |
1mM |
| 9-CIS RETINOIC ACID |
retinoid RXR agonist |
GR101 |
1mM |
| A-23187 |
Calcium ionophore |
CA-100 |
5mg/mL |
| A-3 |
kinase inhibitor |
EI-145 |
5mg/mL |
| AA-861 |
5-lipoxygenase inhibitor |
EI-216 |
5mg/mL |
| acetyl (N)-s-farnesyl-l-cysteine |
farnesylation inhibitor |
G-200 |
5mg/mL |
| ACETYL-FARNESYL-CYSTEINE |
|
G200 |
1mM |
| Ac-Leu-Leu-Nle-CHO |
calpain inhibitor |
P-120 |
5mg/mL |
| ACONITINE |
Sodium channels |
AC-126 |
5mg/mL |
| actinomycin D |
transcription inhibitor |
GR300 |
5mg/mL |
| ADRENIC ACID (22:4, n-6) |
|
FA011 |
1mM |
| AG-1296 |
c-kit, FGF and PDGF kinase inhibitor |
EI303 |
5mg/mL |
| AG1478 |
receptor tyr kinase inhibitor. Broad spectrum |
EI-277 |
5mg/mL |
| AG213 (Tyrphostin 47) |
EGF-R tyrosine kinase inhibitor |
EI-188 |
5mg/mL |
| AG-370 |
PDGF receptor kinase inhibitor |
EI-229 |
5mg/mL |
| AG-490 |
JAK2 inhibitor |
EI-272 |
5mg/mL |
| AG-879 |
NGF receptor inhibitor |
EI-258 |
5mg/mL |
| AGC |
|
G221 |
1mM |
| AGGC |
|
G220 |
1mM |
| Ala-Ala-Phe-CMK |
tripeptidyl peptidase II inhibitor |
PI-123 |
5mg/mL |
| alamethicin |
monovalent cation ionophor |
A-150 |
5mg/mL |
| Alrestatin |
aldose reductase inhibitor |
T-112 |
5mg/mL |
| AM 92016 |
Potassium channels |
AC-115 |
5mg/mL |
| AM-251 |
|
CR108 |
1mM |
| AM-580 |
|
GR104 |
1mM |
| AMANTIDINE |
Misc. channels |
AC-133 |
5mg/mL |
| AMILORIDE |
Calcium channels |
CA-200 |
5mg/mL |
| Amino-1,8-naphthalimide [4-Amino-1,8-naphthalimide] |
PARP inhibitor |
AP-101 |
5mg/mL |
| Aminobenzamide (3-ABA) [3-aminobenzamide (3-ABA)] |
ADP ribose polymerase, apoptosis inhibitor |
G-400 |
5mg/mL |
| AMIODARONE |
Calcium channels |
AC-105 |
5mg/mL |
| ANANDAMIDE (18:2,n-6) |
|
FA026 |
1mM |
| ANANDAMIDE (20:3,n-6) |
|
FA019 |
1mM |
| ANANDAMIDE (20:4, n-6) |
|
FA017 |
1mM |
| ANANDAMIDE (22:4,n-6) |
|
FA020 |
1mM |
| anisomycin |
MAP kinase activator |
ST102 |
5mg/mL |
| aphidicolin |
DNA polymerase inhibitor |
CC-101 |
5mg/mL |
| ARACHIDONAMIDE |
|
FA022 |
1mM |
| ARACHIDONIC ACID (20:4, n-6) |
|
FA003 |
1mM |
| ARACHIDONOYL-PAF |
|
L102 |
1mM |
| aristolochic acid |
phospholipase A2 inhibitor |
EI-175 |
5mg/mL |
| Arvanil |
Vaniloid receptor agonist |
VR101 |
5mg/mL |
| ascomycin (FK-520) |
binds to FKBP inhibits calcineurin |
A-165 |
5mg/mL |
| B581 |
farnesyltransferase inhibitor |
G-235 |
5mg/mL |
| BADGE |
PPARg antagonist |
BL-002 |
5mg/mL |
| bafilomycin A1 |
vaculolar ATPase inhibitor |
CM110 |
0.5mg/mL |
| BAPTA-AM |
cell permeable Ca++ chelator |
CA-411 |
5mg/mL |
| BAY 11-7082 |
IKK kinase inhibitor |
EI-278 |
5mg/mL |
| BAY K-8644 |
Calcium channels |
CA-410 |
5mg/mL |
| BENZAMIL |
Calcium channels |
NA-103 |
5mg/mL |
| BEPRIDIL |
Calcium channels |
AC-104 |
5mg/mL |
| Bestatin |
aminopeptidase inhibitor |
EI-212 |
5mg/mL |
| beta-lapachone |
topoisomerase 1 inhibitor |
GR-308 |
5mg/mL |
| Betulinic acid |
induces mitochondrial permeability pore opening |
AP-301 |
5mg/mL |
| bezafibrate |
PPARalpha agonist |
GR-211 |
5mg/mL |
| Blebbistatin |
Myosin II inhibitor |
EI-315 |
5mg/mL |
| BML-190 |
|
CR104 |
1mM |
| Boc-GVV-CHO |
gamma secretase inhibitor |
PI-128 |
5mg/mL |
| bongkrekic acid |
ANT inhibitor |
CM-113 |
0.5mg/mL |
| brefeldin A |
ARF GEF inhibitor |
G405 |
5mg/mL |
| Bromo-7-nitroindazole [3-Bromo-7-nitroindazole] |
NO synthase inhbitor |
CN252 |
5mg/mL |
| Bromo-cAMP [8-Bromo-cAMP] |
PKA Activator |
CN-115 |
5mg/mL |
| Bromo-cGMP [8-Bromo-cGMP] |
PKG Activator |
CN-205 |
5mg/mL |
| bumetanide |
Na+K+Cl- cotransport inhibitor |
EI-168 |
5mg/mL |
| BW-B 70C |
5 lipoxygenase inhibitor |
EI304 |
5mg/mL |
| C16 CERAMIDE |
|
SL115 |
1mM |
| C2 CERAMIDE |
|
SL100 |
1mM |
| C2 DIHYDROCERAMIDE |
|
SL101 |
1mM |
| C8 CERAMIDE |
|
SL112 |
1mM |
| C8 CERAMINE |
|
SL145 |
1mM |
| C8 DIHYDROCERAMIDE |
|
SL113 |
1mM |
| CA-074-Me |
Cathepsin B inhibitor |
PI126 |
5mg/mL |
| calpeptin |
calpain inhibitor |
PI101 |
5mg/mL |
| calphostin C |
PKC inhibitor |
EI-198 |
0.5mg/mL |
| calyculin A |
PP1, PP2a inhibitor |
EI192 |
0.5mg/mL |
| camptothecin |
topoisomerase 1 inhibitor |
GR301 |
5mg/mL |
| cantharidin |
PP2A inhibitor |
PR-105 |
5mg/mL |
| CAPE |
Antioxidant/ NFkappa B inhibitor |
FR102 |
5mg/mL |
| capsacin(E) |
vanilloid receptor agonist |
EI125 |
5mg/mL |
| capsazepine |
vanilloid receptor antagonist |
NK101 |
5mg/mL |
| CARBACYCLIN |
PPAR delta agonist |
PG035 |
1mM |
| castanospermine |
glucosidase inhibitor |
S-107 |
5mg/mL |
| CDC |
12-Lipoxygenase inhibitor |
EI211 |
5mg/mL |
| Cerulenin |
Fatty acid biosynthesis inhibitor |
G237 |
5mg/mL |
| CGP-37157 |
inhibitor of mitochondrial Na+Ca+2 exchange |
CM-119 |
5mg/mL |
| chelerythrine |
PKC inhibitor |
EI225 |
5mg/mL |
| CIGLITAZONE |
PPAR gamma agonist |
GR205 |
1mM |
| CIMATEROL |
adrenoceptor agonist (beta) |
AC-183 |
5mg/mL |
| CinnGEL 2Me |
PTP1B inhibitor |
PR-115 |
5mg/mL |
| CIRAZOLINE |
adrenoreceptor agonist (alpha) |
AC-136 |
5mg/mL |
| CITCO |
Const. androstane receptor agonist |
GR233 |
5mg/mL |
| CLOFIBRATE |
|
EI160 |
1mM |
| clonidine |
adrenoreceptor agonist (alpha) |
AC-152 |
5mg/mL |
| CLOPROSTENOL Na |
prostaglandin FR receptor agonist |
RA106 |
1mM |
| clozapine |
dopamine antagonist |
D107 |
5mg/mL |
| C-PAF |
PAF receptor agonist |
L120 |
1mM |
| Curcumin |
NFkappaB inhibitor |
EI-135 |
5mg/mL |
| Cyclo [Arg-Gly-Asp-D-Phe-Val] |
integrin inhibitor |
AM-100 |
5mg/mL |
| cycloheximide |
protein synthesis inhibitor |
GR-310 |
5mg/mL |
| cycloheximide-N-ethylethanoate |
FKBP12 inhibitor |
IM-100 |
5mg/mL |
| cyclopamine |
Hedgehog pathway inhibitor |
GR334 |
5mg/mL |
| CYCLOPIAZONIC ACID |
Intracellular calcium |
CA-415 |
5mg/mL |
| cyclosporin A |
calcineurin inhibitor |
A-195 |
5mg/mL |
| cypermethrin |
calcineurin inhibitor |
PR-100 |
5mg/mL |
| cytochalasin B |
F actin capper |
T-108 |
5mg/mL |
| cytochalasin D |
F actin capper |
T-109 |
5mg/mL |
| D12-PROSTAGLANDIN J2 |
PPARgamma agonist |
PG047 |
1mM |
| D609 |
PC-PLC inhibitor |
ST-330 |
5mg/mL |
| damnacanthal |
p56lck inhibitor |
EI-274 |
5mg/mL |
| DANTROLENE |
Intracellular calcium |
AC-100 |
5mg/mL |
| decoyinine |
lowers GTP levels |
A-230 |
5mg/mL |
| Decylubiquinone |
inhibits mitochondrial permeability pore opening |
CM-115 |
5mg/mL |
| deoxymannojirimycin(1) |
mannosidase inhibitor |
S-109 |
5mg/mL |
| deoxynorjrimycin(1) |
glucosidase inhibitor |
S-110 |
5mg/mL |
| Deprenyl |
inhibits glyceraldehyde-3-phosphate dehydrogenase |
EI-240 |
5mg/mL |
| dexamethasone |
corticosteroid |
EI-126 |
5mg/mL |
| DIAZOXIDE |
Potassium channels |
KC-115 |
5mg/mL |
| dibutyrylcyclic AMP |
PKA activator |
CN-125 |
5mg/mL |
| dibutyrylcyclic GMP |
PKA activator |
CN-215 |
5mg/mL |
| DICHLOROBENZAMIL |
Calcium channels |
CA-204 |
5mg/mL |
| DIHOMO-GAMMA-LINOLENIC ACID |
|
FA-009 |
1mM |
| DIHYDROSPHINGOSINE |
|
SL-125 |
1mM |
| DIINDOLYLMETHANE |
AHR agonist |
GR-207 |
1mM |
| DILTIAZEM |
Calcium channels |
CA-205 |
5mg/mL |
| diphenyleneiodonium Cl |
flavoprotein inhibitor |
CN-240 |
5mg/mL |
| dipyridamole |
cGMP phosphodiesterase inhibitor |
EI-127 |
5mg/mL |
| DL-DIHYDROSPHINGOSINE |
|
SL-205 |
1mM |
| DL-PDMP |
|
SL-210 |
1mM |
| DL-PPMP |
|
SL-215 |
1mM |
| DOCOSAHEXAENOIC ACID (22:6 n-3) |
|
FA-002 |
1mM |
| DOCOSAPENTAENOIC ACID |
|
FA-012 |
1mM |
| DOCOSATRIENOIC ACID (22:3 n-3) |
|
FA-010 |
1mM |
| doxorubicin |
topoisomerase II inbhibitor, induces apoptosis |
GR-319 |
5mg/mL |
| DRB |
CKII inhibitor |
EI-231 |
5mg/mL |
| E-4031 |
Potassium channels |
KC-158 |
5mg/mL |
| E6 berbamine |
calmodulin inhibitor |
CA-302 |
5mg/mL |
| E-64-d |
calpain/cathepsin inhibitor |
PI-107 |
5mg/mL |
| Ebselen |
glutathione peroxidase mimetic |
EI-207 |
5mg/mL |
| EHNA HCl |
Phosphodiesterase (PDE2) inhibitor/adenosine deaminase inhibitor |
PD129 |
5mg/mL |
| EICOSA-5,8-DIENOIC ACID (20:2 n-12) |
|
FA024 |
1mM |
| EICOSADIENOIC ACID (20:2 n-6) |
|
FA007 |
1mM |
| EICOSAPENTAENOIC ACID (20:5 n-3) |
|
FA001 |
1mM |
| EICOSATRIENOIC ACID (20:3 n-3) |
|
FA008 |
1mM |
| ENANTIO-PAF C16 |
|
L110 |
1mM |
| epibatidine (+/-) |
nicotinic cholinergic agonist |
C114 |
5mg/mL |
| ESTRADIOL |
estrogen |
BL-093 |
5mg/mL |
| etoposide |
topoisomerase II inhibitor |
GR307 |
5mg/mL |
| FARNESYLTHIOACETIC ACID |
|
G222 |
1mM |
| FCCP |
mitochondrial uncoupler |
CM120 |
5mg/mL |
| FIPRONIL |
Misc. channels |
CM-102 |
5mg/mL |
| FK-506 |
FKBP ligand |
A235 |
5mg/mL |
| FLECAINIDE |
Sodium channels |
AC-130 |
5mg/mL |
| FLUFENAMIC ACID |
Potassium channels |
AC-123 |
5mg/mL |
| FLUNARIZINE |
Calcium channels |
CA-225 |
5mg/mL |
| FLUPROSTENOL |
|
RA105 |
1mM |
| FLUSPIRILINE |
Potassium channels |
AC-116 |
5mg/mL |
| forskolin |
Adenylate cyclase activator |
CN100 |
5mg/mL |
| FPL-64176 |
Calcium channels |
CA-245 |
5mg/mL |
| Fumonisin B1 |
inhibits ceramide synthase |
SL-220 |
5mg/mL |
| Furoxan |
NO donor |
CN-255 |
5mg/mL |
| GAMMA-LINOLENIC ACID (18:3 n-6) |
|
FA006 |
1mM |
| geldanamycin |
HSP90 inhibitor |
EI-280 |
5mg/mL |
| genistein |
tyrosine kinase inhibitor |
EI-147 |
5mg/mL |
| GF-109203X |
PKC inhibitor |
EI-246 |
5mg/mL |
| GINGEROL |
Intracellular calcium |
CA-422 |
5mg/mL |
| Gliotoxin |
Inhibitor of 20S-proteasome chymotrypsin activity |
PI129 |
5mg/mL |
| GLIPIZIDE |
Potassium channels |
AC-120 |
5mg/mL |
| GLYBURIDE |
Potassium channels |
KC-120 |
5mg/mL |
| GM6001 |
broad spectrum MMP inhibitor |
EI-300 |
5mg/mL |
| Go6976 |
PKC inhibitor |
EI-269 |
5mg/mL |
| GRAYANOTOXIN III |
Sodium channels |
NA-135 |
5mg/mL |
| GW-5074 |
cRAF1 kinase inhibitor |
EI-307 |
5mg/mL |
| GW-9662 |
PPARgamma antagonist |
GR-234 |
5mg/mL |
| H7 |
kinase inhibitor |
EI-148 |
5mg/mL |
| H-89 |
PKA inhibitor |
EI-196 |
5mg/mL |
| H9 |
kinase inhibitor |
EI-195 |
5mg/mL |
| HA-1004 |
kinase inhibitor |
EI-184 |
5mg/mL |
| HA1077 |
inhibitor of Rho-dependent kinases |
EI-233 |
5mg/mL |
| HA14-1 |
Bcl-2 ligand induces apoptosis |
CM-122 |
5mg/mL |
| HBDDE |
PKC inhibitor |
EI-273 |
5mg/mL |
| Helenalin |
NFkappaB inhibitor |
EI-301 |
5mg/mL |
| Hinokitiol |
Iron chelator |
FR-110 |
5mg/mL |
| HISTAMINE |
Histamine receptor agonist |
AC-764 |
5mg/mL |
| HNMPA-(AM)3 |
Insulin receptor TK inhibitor |
EI-248 |
5mg/mL |
| Hoechst 33342 (cell permeable) (BisBenzimide) |
DNA minor groove binder |
GR-303 |
5mg/mL |
| Huperzine A [(-)-Huperzine A] |
acetylcholinesterase inhibitor |
C-117 |
5mg/mL |
| IAA-94 |
Misc. channels |
CM-101 |
5mg/mL |
| IB-MECA |
Adenosine receptor agonist |
AC-582 |
5mg/mL |
| IBMX |
PDE inhibitor (broad spec), adenosineR agonist |
PD-140 |
5mg/mL |
| ICRF-193 |
topo II inhibitor that does not cause DNA breaks |
GR-332 |
5mg/mL |
| Ikarugamyin |
inhibits clathrin coated pit mediated endocytosis |
EI313 |
5mg/mL |
| Indirubin |
GSK-3beta inhibitor |
CC-206 |
5mg/mL |
| Indirubin-3'-monoxime |
GSK-3beta inhibitor |
CC-207 |
5mg/mL |
| indomethacin |
cyclooxygenase inhibitor |
EI-131 |
5mg/mL |
| ionomycin |
Ca++ ionophore |
CA-201 |
5mg/mL |
| juglone |
PIN1 inhibitor(?) |
BL-169 |
5mg/mL |
| K252A |
Kinase inhibitor (Broad spectrum) |
EI152 |
0.5mg/mL |
| Kavain (+/-) |
voltage-dependent Na channel inhibitor |
NA136 |
5mg/mL |
| KN-62 |
CaM kinase II inhibitor |
EI230 |
5mg/mL |
| KT-5720 |
PKA inhibitor |
EI199 |
0.5mg/mL |
| L-744,832 |
Ras farnesyltransferase inhibitor |
G-242 |
5mg/mL |
| Latrunculin B |
actin inhibitor |
T-110 |
5mg/mL |
| Lavendustin A |
tyr kinase inhibitor EGF-R) |
EI185 |
5mg/mL |
| L-cis-DILTIAZEM |
Calcium channels |
CA-207 |
5mg/mL |
| LEUKOTOXIN A (9,10-EODE) |
|
LE009 |
0.1mM |
| LEUKOTOXIN B (12,13-EODE) |
|
LE012 |
0.1mM |
| LEUKOTRIENE B4 |
|
LB004 |
0.1mM |
| LEUKOTRIENE C4 |
|
LC004 |
0.1mM |
| LEUKOTRIENE D4 |
|
LD004 |
0.1mM |
| LEUKOTRIENE E4 |
|
LE004 |
0.1mM |
| Leupeptin |
protease inhibitor |
PI-118 |
5mg/mL |
| LFM-A13 |
BTK inhibitor |
EI-295 |
5mg/mL |
| LIDOCAINE |
Sodium channels |
AC-128 |
5mg/mL |
| LINOLEAMIDE |
|
FA023 |
1mM |
| LINOLEIC ACID |
|
FA014 |
1mM |
| LINOLENIC ACID (18:3 n-3) |
|
FA005 |
1mM |
| LIPOXIN A4 |
|
LXA004 |
0.1mM |
| L-NAME |
NO synthesis inhibitor |
CN242 |
5mg/mL |
| L-NASPA |
|
LP101 |
1mM |
| LOPERAMIDE |
Calcium channels |
AC-110 |
5mg/mL |
| LY-171883 |
|
RA101 |
1mM |
| LY-294002 |
PI-3-Kinase inhibitor |
ST420 |
5mg/mL |
| LY-83583 |
Inhibits NO-activation of guanylate cyclase |
CN-200 |
5mg/mL |
| Lycorine |
inhibits TNFalpha production |
GR-313 |
5mg/mL |
| LYSO-PAF C16 |
|
L101 |
1mM |
| LYSOPHOSPHATIDIC ACID |
LPA receptor antagonist |
LP100 |
1mM |
| Manoalide |
Phospholipase A2 inhibitor |
EI177 |
5mg/mL |
| manumycin A |
ras farnesylation inhibitor |
G-236 |
5mg/mL |
| MAPP, D-erythro |
|
SL221 |
1mM |
| MAPP, L-erythro |
|
SL222 |
1mM |
| mastoparan |
activates heterotrimeriuc GTPases |
G410 |
5mg/mL |
| MBCQ |
phosphodiesterase (PDE5) inhibitor |
PD-149 |
5mg/mL |
| MCI-186 |
antioxidant, cytoprotectant |
FR103 |
5mg/mL |
| MDL-28170 |
calpain inhibitor |
PI-130 |
5mg/mL |
| MEAD ACID (20:3 n-9) |
|
FA004 |
1mM |
| MEAD ETHANOLAMIDE |
Cannabinoid receptor agonist |
FA027 |
1mM |
| METHOPRENE ACID |
Retinoid RXR agonist |
GR106 |
1mM |
| methotrexate |
DHFR inhibitor |
CC103 |
5mg/mL |
| METHOXY VERAPAMIL |
Calcium channels |
AC-103 |
5mg/mL |
| Mevinolin (lovastatin) |
Inhibitor HMG-CoA reductase |
G226 |
5mg/mL |
| MG-132 |
proteasome inhibitor |
PI-102 |
5mg/mL |
| Milrinone |
phosphodiesterase (PDE3) inhibitor |
PD-152 |
5mg/mL |
| MINOXIDIL |
Potassium channels |
KC-125 |
5mg/mL |
| MINOXIDIL SULFATE |
Potassium channels |
KC-130 |
5mg/mL |
| MISOPROSTOL, FREE ACID |
Prostaglandin E receptor agonist |
PG-052 |
1mM |
| mitomycin C |
cross links DNA |
GR-311 |
5mg/mL |
| ML7 |
kinase inhibitor |
EI-197 |
5mg/mL |
| ML9 |
kinase inhibitor |
EI-153 |
5mg/mL |
| MnTBAP |
SOD mimetic |
FR-107 |
5mg/mL |
| Monastrol |
Eg5 inhibitor |
GR-322 |
5mg/mL |
| monensin |
Na+ ionophore |
A-248 |
5mg/mL |
| MY-5445 |
phosphodiesterase (PDE5) inhibitor |
PD-155 |
5mg/mL |
| Mycophenolic acid |
Inosine-5'-monophosphate dehydrogenase inhibitor |
A-249 |
5mg/mL |
| N,N-DIMETHYLSPHINGOSINE |
sphingosine kinase inhibitor |
SL-105 |
1mM |
| N9-Isopropylolomoucine |
CDC-2 kinase inhibitor |
CC-202 |
5mg/mL |
| N-ACETYL-LEUKOTRIENE E4 |
|
LEA004 |
0.1mM |
| NapSul-Ile-Trp-CHO |
Cathepsin L inhibitor |
PI-125 |
5mg/mL |
| N-ARACHIDONOYLGLYCINE |
|
FA-029 |
1mM |
| NICARDIPINE |
Calcium channels |
AC-108 |
5mg/mL |
| NIFEDIPINE |
Calcium channels |
CA-210 |
5mg/mL |
| NIFLUMIC ACID |
Misc. channels |
AC-134 |
5mg/mL |
| Nigericin |
induces intracellular acidification |
CA-421 |
5mg/mL |
| NIGULDIPINE |
Calcium channels |
CA-216 |
5mg/mL |
| Nimesulide |
Cox 2 inhibitor |
EI287 |
5mg/mL |
| NIMODIPINE |
Calcium channels |
CA-211 |
5mg/mL |
| NITRENDIPINE |
Calcium channels |
CA-212 |
5mg/mL |
| N-LINOLEOYLGLYCINE |
|
FA-030 |
1mM |
| nocodazole |
tubulin inhibitor |
T101 |
5mg/mL |
| N-PHENYLANTHRANILIC (CL) |
Misc. channels |
AC-132 |
5mg/mL |
| NPPB |
Misc. channels |
CM-100 |
5mg/mL |
| NS-1619 |
Potassium channels |
KC-127 |
5mg/mL |
| NS-398 |
Cox-2 inhibitor |
EI-261 |
5mg/mL |
| NSC-95397 |
CDC25 phosphatase inhibitor |
EI-309 |
5mg/mL |
| OBAA |
phospholipase A2 inhibitor |
ST315 |
5mg/mL |
| okadaic acid |
PP1 PP2A inhibitor |
EI181 |
0.5mg/mL |
| oligomycin A |
Fo ATP synthase inhibitor |
CM-111 |
5mg/mL |
| olomoucine |
CDK inhibitor |
CC-200 |
5mg/mL |
| ouabain |
Na+K+ATPase inhibitor |
CM109 |
5mg/mL |
| PAF C16 |
PAF receptor agonist |
L100 |
1mM |
| PAF C18 |
PAF receptor agonist |
L105 |
1mM |
| PAF C18:1 |
PAF receptor agonist |
L107 |
1mM |
| PALMITYLETHANOLAMIDE |
Cannabinoid CB2 agonist |
FA018 |
1mM |
| Parthenolide |
IkappaB kinase inhibitor |
T-113 |
5mg/mL |
| PAXILLINE |
Potassium channels |
KC-155 |
5mg/mL |
| PCA 4248 |
PAF antagonist |
L-133 |
5mg/mL |
| PCO-400 |
Potassium channels |
KC-131 |
5mg/mL |
| PD 98059 |
MEK inhibitor |
EI-360 |
5mg/mL |
| PENITREM A |
Potassium channels |
KC-157 |
5mg/mL |
| pepstatin |
protease inhibitor |
PI-120 |
5mg/mL |
| PHENAMIL |
Sodium channels |
AC-131 |
5mg/mL |
| Phenanthridinone [6(5H)-Phenanthridinone] |
PARP inhibitor |
AP-100 |
5mg/mL |
| Phenoxybenzamine |
calmodulin antagonist |
CA305 |
5mg/mL |
| PHENTOLAMINE |
Potassium channels |
AC-121 |
5mg/mL |
| PHENYTOIN |
Sodum channels |
AC-125 |
5mg/mL |
| phorbol 12 myristate 13 acetate |
PKC activator |
PE-160 |
5mg/mL |
| PHOSPHATIDIC ACID, DIPALMITOYL |
|
LP103 |
1mM |
| Piceatannol |
Syk inhibitor |
EI-271 |
5mg/mL |
| pifithrin |
p53 inhibitor |
GR-325 |
5mg/mL |
| PIMOZIDE |
Calcium channels |
AC-109 |
5mg/mL |
| PINACIDIL |
Potassium channels |
AC-118 |
5mg/mL |
| piroxicam |
COX1 inhibitor |
EI219 |
5mg/mL |
| PP1 |
src family trosine kinase inhibitor |
EI-275 |
5mg/mL |
| PP2 |
Src family tyrosine kinase inhibitor |
EI-297 |
5mg/mL |
| prazocin |
adrenoreceptor agonist |
AC-146 |
5mg/mL |
| Pregnenolone 16alpha carbonitrile |
PXR/SXR agonist |
S620 |
5mg/mL |
| PRIMA-1 |
p53 reactivator |
GR333 |
5mg/mL |
| PROCAINAMIDE |
Sodium channels |
AC-127 |
5mg/mL |
| PROPAFENONE |
Potassium channels |
AC-124 |
5mg/mL |
| propidium iodide |
DNA intercalator |
AP401 |
5mg/mL |
| propranolol (S-) |
adrenoceptor antagonist (beta) |
AR107 |
5mg/mL |
| PROSTAGLANDIN A1 |
|
PG001 |
1mM |
| PROSTAGLANDIN A2 |
|
PG002 |
1mM |
| PROSTAGLANDIN B1 |
|
PG003 |
1mM |
| PROSTAGLANDIN B2 |
|
PG004 |
1mM |
| PROSTAGLANDIN D2 |
|
PG005 |
1mM |
| PROSTAGLANDIN E1 |
|
PG006 |
1mM |
| PROSTAGLANDIN E2 |
|
PG007 |
1mM |
| PROSTAGLANDIN F1a |
|
PG010 |
1mM |
| PROSTAGLANDIN F2a |
|
PG008 |
1mM |
| PROSTAGLANDIN I2 Na |
|
PG011 |
1mM |
| PROSTAGLANDIN J2 |
|
PG033 |
1mM |
| puromycin |
protein synthesis inhibitor |
GR-312 |
5mg/mL |
| quercetin |
kinase inhibitor plus other |
AC1142 |
5mg/mL |
| QUINIDINE |
Sodium channels |
AC-129 |
5mg/mL |
| QUININE |
Potassium channels |
AC-122 |
5mg/mL |
| QX-314 |
Sodium channels |
NA-134 |
5mg/mL |
| rapamycin |
FRAP inhibitor very potent! |
A-275 |
5mg/mL |
| resveratrol |
SIRT1 activator |
FR-104 |
5mg/mL |
| RETINOIC ACID, ALL TRANS |
Retinoid RAR agonist |
GR100 |
1mM |
| REV-5901 |
5-Lipoxygenase inhibitor |
EI209 |
1mM |
| RG-14620 |
EGF-R tyrosine kinase inhibitor |
EI-253 |
5mg/mL |
| RHC-80267 |
DAG lipase inhibitor |
ST-300 |
5mg/mL |
| RK-682 |
VHR phosphatase inhibitor |
PR-112 |
5mg/mL |
| Ro 20-1724 |
phosphodiesterase (PDE4 ) inhibitor |
EI-117 |
5mg/mL |
| Ro 31-8220 |
PKC inhibitor |
EI-283 |
5mg/mL |
| Rolipram |
phosphodiesterase (PDE4 ) inhibitor |
PD-175 |
5mg/mL |
| roscovitine |
CDK inhibitor |
CC205 |
5mg/mL |
| Rottlerin |
inhibitor of p38 activated kinases |
EI270 |
5mg/mL |
| RWJ-60475-(AM)3 |
CD45 phosphatase inhibitor |
PR-110 |
5mg/mL |
| RYANODINE |
Intracellular calcium |
CA-450 |
5mg/mL |
| SB 202190 |
MAP kinase inhibitor |
EI-294 |
5mg/mL |
| SB 203580 |
Suppressor of MAPKAP kinase-2 |
EI-286 |
5mg/mL |
| SB-415286 |
GSK3beta inhibitor |
EI311 |
5mg/mL |
| SB-431542 |
ALK4, ALK5, ALK7 inhibitor |
EI314 |
5mg/mL |
| SDZ-201106 |
Sodium channels |
NA-116 |
5mg/mL |
| serotonin |
serotonin receptor |
NS-820 |
5mg/mL |
| S-FARNESYL-L-CYSTEINE ME |
|
G-201 |
1mM |
| Shikonin |
apoptosis inducer, p53 dependent |
CT115 |
5mg/mL |
| siguazodan |
phosphodiesterase (PDE3) inhibitor |
PD-179 |
5mg/mL |
| SKF-96365 |
Calcium channels |
CA-230 |
5mg/mL |
| SP-600125 |
JNK inhibitor |
EI305 |
5mg/mL |
| SPHINGOSINE |
PKC inhibitor |
EI-155 |
1mM |
| Splitomycin |
sir2p inhibitor |
GR-331 |
5mg/mL |
| SQ22536 |
adenylate cyclase inhibitor |
CN-140 |
5mg/mL |
| SQ-29548 |
Thromboxane A2 antagonist |
RA-103 |
1mM |
| staurosporine |
kinase inhibitor |
EI-156 |
5mg/mL |
| SU-4312 |
VEGF-R (Flk-1) tyrosine kinase |
EI-306 |
5mg/mL |
| swainsonine |
protein glycosylation inhibitor |
S-112 |
5mg/mL |
| tamoxifen |
estrogen antagonist |
S-650 |
5mg/mL |
| Tanshinone IIA |
AP-1 inhibitor |
GR-336 |
5mg/mL |
| taxol = paclitaxel |
microtubule stabilizer |
T-104 |
5mg/mL |
| TETRAHYDROCANNABINOL-7-OIC ACID |
PPARgamma agonist |
L-126 |
1mM |
| TETRANDRINE |
Calcium channels |
CA-260 |
5mg/mL |
| thalidomide |
TNFalpha synthesis inhibitor |
T-115 |
5mg/mL |
| THAPSIGARGIN |
Intracellular calcium |
PE-180 |
5mg/mL |
| Thiocitrulline [L-Thiocitrulline HCl] |
bNOS inhibitor |
CN-257 |
5mg/mL |
| Thiorphan |
neutral endopeptidase inhibitor |
PI-113 |
5mg/mL |
| TMB-8 |
Intracellular calcium |
EI-110 |
5mg/mL |
| TOLAZAMIDE |
Potassium channels |
KC-135 |
5mg/mL |
| TOLBUTAMIDE |
Potassium channels |
AC-117 |
5mg/mL |
| Tosyl-Phe-CMK (TPCK) |
serine protease inhibitor |
PI-122 |
5mg/mL |
| TPEN |
cell permable heavy metal chelator |
AP-300 |
5mg/mL |
| Trequinsin |
phosphodiesterase (PDE3) inhibitor |
PD-180 |
5mg/mL |
| trichostatin-A |
histone deacetylase inhibitor |
GR-309 |
5mg/mL |
| trifluoperazine |
calmodulin inhibitor-possibly only at high concentrations! |
CA-310 |
5mg/mL |
| TRIM |
bNOS/iNOS inhibitor |
CN-266 |
5mg/mL |
| Triptolide |
inhibits NFkappaB transcriptional activation |
AP-304 |
5mg/mL |
| TTNPB |
Retinoid RAR agonist |
GR105 |
1mM |
| tunicamycin |
glycosylation inhibitor |
CC-104 |
5mg/mL |
| tyrphostin 1 |
Calcineurin inhibitor |
EI-190 |
5mg/mL |
| tyrphostin 9 |
PDGF-R tyrosine kinase inhibitor |
EI-215 |
5mg/mL |
| tyrphostin AG-126 |
tyrosine kinase inhibitor |
EI-263 |
5mg/mL |
| tyrphostin AG-370 |
PDGF-R tyrosine kinase inhibitor |
EI-229 |
5mg/mL |
| tyrphostin AG-825 |
HER-1,2 tyrosine kinase inhibitor |
EI-267 |
5mg/mL |
| Tyrphostin-8 |
Calcineurin inhibitor |
PR-113 |
5mg/mL |
| U-0126 |
MEK inhibitor |
EI282 |
5mg/mL |
| U-37883A |
Potassium channels |
KC-159 |
5mg/mL |
| U-46619 |
Thromboxane receptor agonist |
PG023 |
1mM |
| U-50488 |
Calcium channels |
N-701 |
5mg/mL |
| U73122 |
PLC inhibitor |
ST-391 |
5mg/mL |
| U-74389G |
superoxide/free-radical inhibitor |
FR-100 |
5mg/mL |
| U-75302 |
Leukotriene B4 receptor antagonist |
RA102 |
0.1mM |
| valinomycin |
K+ ionophore |
KC-140 |
5mg/mL |
| VERAPAMIL |
Calcium channels |
CA-215 |
5mg/mL |
| VERATRIDINE |
Sodium channels |
NA-125 |
5mg/mL |
| vinblastine |
tubulin inhibitor |
T116 |
5mg/mL |
| vinpocetine |
phosphodiesterase (PDE1) inhibitor |
PD-185 |
5mg/mL |
| W7 |
calmodulin antagonist |
CA-320 |
5mg/mL |
| WIN 55,212-2 |
cannabinoid CB1/CB2 agonist |
CR-105 |
1mM |
| Wiskostatin |
N-WASP inhibitor |
T-126 |
5mg/mL |
| wortmannin |
PI3Kinase, other kinases inhibitor |
ST-415 |
5mg/mL |
| WY-14643 |
PPAR alpha agonist |
GR-200 |
1mM |
| Xestospongin C |
IP3 receptor blocker |
CA409 |
0.5mg/mL |
| Y-27632 |
ROCK inhibitor |
EI-299 |
5mg/mL |
| YC-1 |
guanylyl cyclase stimulator |
CN-223 |
5mg/mL |
| yohimbine |
adrenoreceptor antagonist (alpha) |
AC-161 |
5mg/mL |
| YS035 |
Calcium channels |
AC-106 |
5mg/mL |
| zaprinast |
phosphodiesterase (PDE1) inhibitor |
PD-190 |
5mg/mL |
| zardaverine |
phosphodiesterase (PDE1/2) inhibitor |
PD-195 |
5mg/mL |
| ZL3VS |
proteasome inhibitor |
ZW-9170 |
5mg/mL |
| ZM226600 |
Potassium channels |
AC-114 |
5mg/mL |
| ZM336372 |
raf inhibitor |
EI-298 |
5mg/mL |
| Z-prolyl-prolinal |
prolyl endopeptidase inhibitor |
PI-112 |
5mg/mL |
| zVAD-FMK |
Caspase inhibitor (broad spectrum) |
P-416 |
5mg/mL |
